A Look Into Sanofi Inc's Price Over Earnings
AlphaValue/Baader Europe Trims Sanofi PT, Reiterates Buy Rating
The Zacks Analyst Blog Highlights ServiceNow, AMD, Sanofi, Team and United-Guardian
Top Research Reports for ServiceNow, AMD & Sanofi
Express News | Fulcrum Therapeutics Inc - Sanofi to Terminate Collaboration and License Agreement With Fulcrum
Sanofi Appoints Jean-Paul Kress to Board of Directors
Why Is Sanofi (SNY) Among the Best European Dividend Stocks To Buy Now?
Sanofi's 21-Valent Pneumococcal Vaccine Enters Phase III
Sanofi, SK Bioscience Extend Collaboration to Develop Pneumococcal Disease Vaccine for Toddlers, Infants
Press Release: Sanofi Initiates Phase 3 Program for PCV21 and Expands Collaboration With SK Bioscience for Next-generation Pneumococcal Conjugate Vaccines
Teva Pharmaceutical, Li Auto, And Darden Restaurants Are Among Top Large Cap Gainers Last Week (December 16-20): Are The Others In Your Portfolio?
Trending Stocks in Bearish Pre-holiday Week for U.S. Stock Market
Sanofi's Tolebrutinib Receives FDA Breakthrough Therapy Designation for NrSPMS
This week's US stock market hot stocks | The US version of HAIDILAO exceeds expectations! Darden Restaurants' stock price skyrocketed nearly 15%; Boeing, a component of the Dow, rose 4.36% against the trend this week, receiving a large order for 737 MAX a
This week, the Dow Jones Industrial Average has fallen by 3.39%, closing at 42,342.24 points; during the same period, the S&P 500 Index has decreased by 3.04%, closing at 5,867.08 points; the Nasdaq has dropped by 2.78%, closing at 19,372.77 points.
Cytokinetics Says Sanofi Acquiring Rights for Aficamten in Greater China
Express News | The Municipal Management Bureau has reached a preliminary consensus with Sanofi on the introduction of an innovative product for type 1 diabetes.
Express News | Sanofi and Jixing have reached an agreement on Aficamten in the Greater China market.
Express News | Cytokinetics Inc - Eligible for up to $150 Million in Milestone Payments From Sanofi
Express News | Cytokinetics Announces Sanofi Acquired Rights to Develop and Commercialize Aficamten in Greater China
Sanofi: Kress Was the CEO of MorphoSys From 2019 Until It Was Acquired by Novartis in 2024